Salt Lake City
Alta Sciences
JUNE 26, 2025
All Rights Reserved. Cookie Policy | Privacy Policy Have a question? × Id be happy to help.
Drug Development Testimonials Webinar 
40 
Gretchen Green
Alta Sciences
JUNE 26, 2025
All Rights Reserved. Cookie Policy | Privacy Policy Have a question? × Id be happy to help.
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Business Leaders Review - The Heart and Strategy Behind Altasciences' Marketing Evolution
Alta Sciences
JULY 3, 2025
All Rights Reserved. Cookie Policy | Privacy Policy Have a question? × Id be happy to help.
Digital Product Catalog: The Medical Device Marketer’s Guide
Perficient: Drug Development
FEBRUARY 27, 2024
Sustainability information, papers and journey articles, and testimonials are all going to earn bonus points with your audiences, especially if you can make those a bit interactive too. Whatever layers of information you decide to include, make sure it is easy to access from one location. But can we go deeper?
Analysis Life Sciences Thank You What We Expect the FDA to do in July 2023
Agency IQ
JUNE 29, 2023
to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. To implement that authority, FDA published a final rule in the Federal Register on September 15, 2015 [80 FR 55237] which revised 21 CFR 1.94
Analysis Life Sciences Thank You What We Expect the FDA to do in November 2023
Agency IQ
OCTOBER 27, 2023
to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. To implement that authority, FDA published a final rule in the Federal Register on September 15, 2015 [80 FR 55237] which revised 21 CFR 1.94 to include devices.
Analysis Life Sciences Thank You What We Expect the FDA to do in October 2023
Agency IQ
SEPTEMBER 29, 2023
The following legislative requirements are due within the next two months: Legislation Program Tag Requirement Due Date FDORA, Section 3202 Orphan Drug Program FDA shall publish final guidance related to the draft guidance titled, “Rare Diseases: Common Issues in Drug Development.” to include devices.
Let's personalize your content